// App-Quantinova.ai

211 : NOX1/NOX4 inhibition blocks the profibrotic activity of scleroderma fibroblasts

Researchers

Presenter

  • Hannah Murphy-Marshman

Principal Investigators

  • Xu Shiwen

  • Katherine Quensel

  • Richard Stratton

  • Andrew Leask

Medical Centers

  • Dentistry, Western University, London, ON, CANADA

  • Department of Rheumatology, University College London, London, UK

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • NADPH oxidase 1

  • Nicotinamide-adenine dinucleotide phosphate oxidase 4

Drug/Treatment

  • Setanaxib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved